Physician profile
Mary E Robbins
NPI 1336275627
$2,380.85
in general payments reported to CMS, 2019-2025
34 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $296 · 2021: $314 · 2022: $509 · 2023: $445 · 2024: $255 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $510.46 | 2019-2024 | Wegovy |
| Abbvie INC. | $288.94 | 2019-2024 | Vraylar, Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $147.67 | 2022-2025 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Mayne Pharma Commercial LLC | $131.66 | 2022-2025 | |
| Pfizer INC. | $125.71 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $97.62 | 2020 | |
| Astellas Pharma US INC | $97.38 | 2019-2025 | Veozah, Myrbetriq |
| Organon LLC | $94.58 | 2024-2025 | Nexplanon |
| Bausch Health US, LLC | $88.59 | 2019-2022 | |
| Sage Therapeutics, LLC | $79.53 | 2025 | Zurzuvae |
| Scynexis, INC. | $65.60 | 2021-2022 | |
| Agile Therapeutics, INC. | $63.57 | 2021-2022 | |
| Therapeuticsmd, INC. | $58.64 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.31 | 2023-2025 | |
| Aspira Women'S Health INC | $53.91 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $40.81 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $39.14 | 2019-2020 | |
| Shield Therapeutics INC | $36.87 | 2023-2024 | Accrufer |
| Daiichi Sankyo INC. | $36.69 | 2020-2022 | |
| Exeltis, USA INC. | $36.31 | 2023-2025 | Slynd |
| Lupin INC. | $23.43 | 2020 | |
| Northgate Technologies, INC. | $20.26 | 2023 | Nti Branded Other (Nti) |
| Takeda Pharmaceuticals U.S.A., INC. | $19.25 | 2022 | |
| Coopersurgical, INC. | $19.25 | 2024 | Wallach Cryosurgical Equipment |
| Exact Sciences Corporation | $18.65 | 2025 | Cologuard Collection Kit |
| Monaghan Medical Corporation | $18.34 | 2023 | Aerobika |
| Olympus America INC. | $17.53 | 2019 | |
| Solventum Corporation | $17.06 | 2025 | Prevena |
| Axonics, INC. | $16.55 | 2024 | Axonics |
| Lilly USA, LLC | $13.41 | 2022 | |
| Avion Pharmaceuticals | $12.82 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $12.35 | 2021 | |
| Allergan, INC. | $11.69 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Robbins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.